Tenvir EM
$55 – $150
Generic Drugs | Tenofovir / Emtricitabine |
Manufacturer | Cipla Ltd |
Pack Size | Price | Price Per Unit | Qty | Add To Cart |
---|---|---|---|---|
90 Tablet S | $150 | $1.66 | ||
60 Tablet S | $105 | $1.75 | ||
30 Tablet S | $55 | $1.83 |
Tenvir EM
Tenvir EM is a nucleoside reverse transcriptase inhibitor (NRTI), which is used for treating HIV infection. This drug filters out the HIV from the blood, it does not cure the disease but is helpful in preventing AIDS. It comes as a capsule, a tablet, and a solution.
Common side effects of this medicine include dizziness, Abdominal or stomach pain, nausea, diarrhea, headache. It may also lead to some other serious side effects such as fever, chills, pain during urination, fatigue, chest pain chest pain, skin discoloration, trouble falling asleep, numbness, burning, or tingling in the hands, arms, feet, or legs, rash, itching , depression, muscle stiffness. Seek immediate medical attention in case you notice any serious side effects or if any mild side effect stays long.
Information given here is based on the salt and content of the medicine. Effect and uses of medicine may vary from person to person. It is advicable to consult a HIV Specialist before using this medicine.
Drug = Tenofovir + Emtricitabine
Strength = 300 Mg + 20 Mg
Manufacturer = Cipla Ltd.
How To Take
Take Tenvir EM medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Tenvir EM Tablet is to be taken with food.
Dosage
Tenvir Tablet
Tenvir-EM Tablet
Tenvir L Tablet
Tenvir AF 25 Mg Tablet
Side Effects
Nausea
Vomiting
Diarrhea
Flatulence
Insomnia (difficulty in sleeping)
Headache
Depression
Rash
Warnings
Pregnancy : Tenvir EM Tablet is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.
Breast-feeding : Tenvir EM Tablet is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may advise you to discontinue the drug or to discontinue breastfeeding based on your clinical condition.
Immune reconstitution syndrome : Tenvir EM Tablet should be used with caution due to the increased risk of Immune reconstitution syndrome. Report any unusual symptoms to the doctor immediately. Appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be required based on the clinical condition of the patient.
Fat redistribution : Tenvir EM Tablet may cause fat gain or fat loss from the body. This may result in peripheral wasting, facial wasting, breast enlargement, and Cushingoid appearance. Close monitoring of body weight and body fat distribution is necessary while receiving this medicine. Any changes in the body should be informed to the doctor on priority. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.
Lactic acidosis : Tenvir EM Tablet should be used with caution due to the increased risk of Lactic acidosis. Report any unusual symptoms to the doctor immediately. Appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be required based on the clinical condition.
Opportunistic infections : The patients receiving this medicine may develop opportunistic infections such as pneumonia, herpes virus infections, etc. Report any unusual symptoms to the doctor immediately. Appropriate patient/caregiver education, corrective measures, dose adjustments, or replacement with a suitable alternative may be required based on the clinical condition.
Hemodialysis : Tenvir EM Tablet is not recommended for use in patients requiring hemodialysis. Replacement with a suitable alternative should be considered based on the clinical condition.
Uses
Tenvir EM Tablet is used in the treatment of human immunodeficiency virus (HIV) infection. Tenvir EM Tablet is used in a combination with safe-sex practices to reduce the risk of sexually acquired HIV infection in adults at high risk.
Reviews
There are no reviews yet.